Metropolis Healthcare Ltd

We are pleased to inform you that our Managing Director Ms. Ameera Shah will be participating as a Keynote Speaker at the #Samvaad event of Purvodaya 2023, organized by Vinod Gupta School of Management, IIT Kharagpur Samvaad in Purvodaya 2023 is a leadership talk series where renowned personalities impart their knowledge and engage with students. In an event which is organized around the theme ‘Prism of Possibilities’, Ms. Ameera Shah will be sharing her varied & rich experiences in building and establishing Metropolis as a leader in the diagnostics industry. Purvodaya #MetropolisLabs #Healthcare #Diagnostics #Inspiring #ThoughtLeader #PowerfulBusinessWoman #Entrepreneurship #Leadership #Samvaad #MetropolisLabs #Healthcare #Diagnostics #Inspiring #ThoughtLeader #PowerfulBusinessWoman #Entrepreneurship #Leadership

As we await to hear the #unionbudget2023 tomorrow, Ms. Ameera Shah, Promoter and MD, Metropolis Labs joins other diagnostic industry players to share her expectations from the Union Budget with #ETHealthWorld. Sharing here the excerpts of her quote: “As we prepare for the post-pandemic era, it is crucial to boost the economy through building and preparing a healthcare infrastructure so that people have greater access to quality and critical healthcare services. To achieve this vision, the Union Budget 2023-2024 should help fuel innovation, R&D, and healthcare expenditure as an investment into future human capital, which will set the pace for propelling the industry forward. The government should consider zero-rating GST on healthcare services. It will ensure eligibility for input tax credits, which may help to reduce the cost of said services, and a refund of unutilized input tax credits should also be allowed to provide additional working capital to industry players. The input credit for GST paid can enable the healthcare providers to pass it on to the patients in the form of lower pricing and the services can be made accessible to patients in smaller towns. Along with this, it is important to address the shortage of healthcare professionals (doctors, nurses, and technical staff) willing to work in Tier 2/3 cities and look at non-traditional ways to double the number of doctors. In addition, the government should prioritize lower-cost financing through tax breaks for both existing and new healthcare projects. Also, they should provide a 15-year tax holiday for new projects and a 10-year tax break for existing projects as reinvestment support. Declaring healthcare, a national priority sector and classifying it along the same lines as agriculture (priority-sector lending) will allow banks to lend to private healthcare institutions for longer periods of time and at lower interest rates. The future of healthcare has enormous opportunities for India to become a global healthcare destination.” Check out the link to read the entire article. #MetropolisLabs #Healthcare #Diagnostics #DiagnosticLeaderhttps://health.economictimes.indiatimes.com/news/diagnostics/union-budget-2023-24-make-diagnostics-cost-effective-with-gst-exemption/97453694 #unionbudget2023 #ETHealthWorld #MetropolisLabs #Healthcare #Diagnostics #DiagnosticLeader

Metropolis’ Group Company #HITECHDiagnosticCentre bags the ‘Silver Award’ for Excellence in Pathology Services at the 8th India Health and Wellness Awards by IHW Council. Established in the year 1986, Hitech Diagnostic Centre is a well-known diagnostics laboratory chain in the Tamil Nadu with a network of 17 laboratories and 68 collection centres strategically spread across the states of Tamil Nadu and Union Territory of Pondicherry. It is the 2nd largest player in Chennai and is a leader in non-Chennai markets in the state of Tamil Nadu. Hitech has been catering to the mid-segment of the market and has a larger B2C footprint. It has a test menu of 1,100+ tests ranging from routine to highly impenetrable molecular and genetic essays. Metropolis Healthcare’s Dr. Nilesh Shah, President and Chief of Research and Innovation and Dr. Kirti Chadha, Chief Scientific Officer and Group Head – CSR received the award at the event held in Mumbai. #MetropolisHealthcare #MetropolisLabs #HitechDiagnostics #IHWCouncil #HealthandWellness #Recognition #MetropolisScientificexpert #DiagnosticsLeader #Science #Excellence #Innovation #PathologyServices #HITECHDiagnosticCentre #MetropolisHealthcare #MetropolisLabs #HitechDiagnostics #IHWCouncil #HealthandWellness #Recognition #MetropolisScientificexpert #DiagnosticsLeader #Science #Excellence #Innovation #PathologyServices

Metropolis’ Group Company bags the ‘Silver Award’ for Excellence in Pathology Services at the 8th India Health and Wellness Awards by IHW Council. Established in the year 1986, Hitech Diagnostic Centre is a well-known diagnostics laboratory chain in the Tamil Nadu with a network of 17 laboratories and 68 collection centres strategically spread across the states of Tamil Nadu and Union Territory of Pondicherry. It is the 2nd largest player in Chennai and is a leader in non-Chennai markets in the state of Tamil Nadu. Hitech has been catering to the mid-segment of the market and has a larger B2C footprint. It has a test menu of 1,100+ tests ranging from routine to highly impenetrable molecular and genetic essays. Metropolis Healthcare’s Dr. Nilesh Shah, President and Chief of Research and Innovation and Dr. Kirti Chadha, Chief Scientific Officer and Group Head – CSR received the award at the event held in Mumbai. #HITECHDiagnosticCentre #MetropolisHealthcare #MetropolisLabs #HitechDiagnostics #IHWCouncil #HealthandWellness #Recognition #MetropolisScientificexpert #DiagnosticsLeader #Science #Excellence #Innovation #PathologyServices

We are excited to inform you that we have won the ‘Gold Award’ for Excellence in High-end Diagnostic Services at the 8th India Health and Wellness Awards by IHW Council. At Metropolis, we have always been at the forefront of clinical validation of technologies, tests and platforms that directly ensure an accurate timely diagnosis to the patient, including Digital Pathology (Whole Slide Imaging), FDA approved Immunotherapy, targeted therapy biomarkers, liquid biopsy, medical genetics, analytical chemistry, pharmacogenomics, COVID diagnostic & prognostic assays etc. This esteemed award is in recognition of our ongoing efforts in nurturing and expanding the scope for Oncology, Prenatal Testing, Transplant Immunology, Infectious and Chronic Diseases through Next Generation Sequencing and Artificial Intelligence. We thank and congratulate all our scientific and technical team for their outstanding contribution in the area of research and innovation at Metropolis. Metropolis Healthcare’s Dr. Nilesh Shah, President and Chief of Research and Innovation and Dr. Kirti Chadha, Chief Scientific Officer and Group Head – CSR received the award at the event held in Mumbai. #IHWCouncil #HealthandWellness #Recognition #MetropolisScientificexpert #DiagnosticsLeader #Science #Excellence #Innovation #MetropolisHealthcare #MetropolisLabs #IHWCouncil #HealthandWellness #Recognition #MetropolisScientificexpert #DiagnosticsLeader #Science #Excellence #Innovation #MetropolisHealthcare #MetropolisLabs

We are excited to inform you that we have won the ‘Gold Award’ for Excellence in High-end Diagnostic Services at the 8th India Health and Wellness Awards by IHW Council. At Metropolis, we have always been at the forefront of clinical validation of technologies, tests and platforms that directly ensure an accurate timely diagnosis to the patient, including Digital Pathology (Whole Slide Imaging), FDA approved Immunotherapy, targeted therapy biomarkers, liquid biopsy, medical genetics, analytical chemistry, pharmacogenomics, COVID diagnostic & prognostic assays etc. This esteemed award is in recognition of our ongoing efforts in nurturing and expanding the scope for Oncology, Prenatal Testing, Transplant Immunology, Infectious and Chronic Diseases through Next Generation Sequencing and Artificial Intelligence. We thank and congratulate all our scientific and technical team for their outstanding contribution in the area of research and innovation at Metropolis. Metropolis Healthcare’s Dr. Nilesh Shah, President and Chief of Research and Innovation and Dr. Kirti Chadha, Chief Scientific Officer and Group Head – CSR received the award at the event held in Mumbai. #IHWCouncil #HealthandWellness #Recognition #MetropolisScientificexpert #DiagnosticsLeader #Science #Excellence #Innovation #MetropolisHealthcare #MetropolisLabs

Metropolis Labs MD Ms. Ameera Shah shares her takeaways with #ETHealthWorld from the current year and the Lifesciences Outlook for the year 2023. #MetropolisLabs #Healthcare #DiagnosticsLeader #Thoughtleadership #lifescienceshttps://www.youtube.com/watch?v=hYvQ5SsaBEA #ETHealthWorld #MetropolisLabs #Healthcare #DiagnosticsLeader #Thoughtleadership #lifesciences

NERCON 2022 is the 31st Annual Conference of the Northeast Regional Chapter of the Indian Association of Pathologists and Microbiologists (NERC IAPM). It is the academic and scientific body of pathologists and microbiologists of 8 states of India which include 7 North Eastern States and Sikkim. Around 350 delegates attended this prestigious conference which had a series of scientific sessions and a trade fair. Metropolis Colleagues @Dr. Kirti Chadha, Chief Scientific Officer and Dr. K V Santosh, Senior Consultant Pathologist addressed a session on the updates of Breast and Lung Cancer – Morphology to Molecular and Gastrointestinal Mucosal Biopsies in Pathology, respectively. @Dr Ronica Baruah, Director & Chief of Lab Services, Quality Manager, Ekopath Metropolis Lab was the Organizing Secretary. #NERCON2022 #MolecularOncology #ScientificThoughtLeader #DiagnosticsLeader #NERCON2022 #MolecularOncology #ScientificThoughtLeader #DiagnosticsLeader

We are happy to inform you that #MetropolisSeniorScientificExpert @Dr Ronica Baruah, Director & Chief of Lab Services, Quality Manager, Ekopath Metropolis Lab played an instrumental role in executing the three-day conference of NERCON 2022, as an Organizing Secretary. #NERCON2022 #MolecularOncology #ScientificThoughtLeader #DiagnosticsLeader #MetropolisSeniorScientificExpert #NERCON2022 #MolecularOncology #ScientificThoughtLeader #DiagnosticsLeader